<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>LA</div>
Understanding current and past LABORATORIO REIG Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We recommend to make use of LABORATORIO REIG JOFRE S A fundamental analysis to find out if markets are right now mispricing the company. Strictly speaking this interface allows you to check out available fundamental indicators of LABORATORIO REIG JOFRE as well as the relationship between them. We found twenty-seven available financial indicators for LABORATORIO REIG, which can be compared to its peers in the sector. To make sure the equity is not overpriced, please verify all LABORATORIO REIG JOFRE S A financials, including its Current Valuation, Price to Sales, Net Income, as well as the relationship between Price to Earning and Gross Profit .
View Fundamentals For
With this module, you can determine LABORATORIO financials for your investing period. You should be able to track the changes in LABORATORIO REIG individual fundamental values over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Chance of Financial Distress

LABORATORIO REIG JOFRE S A has more than 61 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


LABORATORIO REIG competes with ATRYS HEALTH. Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and nutritional supplements. Laboratorio Reig Jofre, S.A. was founded in 1929 and is based in Barcelona, Spain. LABORATORIO REIG operates under Drug Manufacturers - Specialty Generic classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1000 people.
Foreign Associate  USA
InstrumentSpain Stock View All
ExchangeMadrid SE C.A.T.S.
Business AddressAv de les Flors
IndustryDrug Manufacturers - Specialty & Generic
Phone34 93 480 67 10
CurrencyEUR - Euro

LABORATORIO REIG Key Financial Ratios

LABORATORIO Financial Ratios Relationships

LABORATORIO REIG JOFRE S A is currently regarded as top stock in debt to equity category among related companies. It is currently regarded as top stock in earnings per share category among related companies creating about  0.01  of Earnings Per Share per Debt to Equity. The ratio of Debt to Equity to Earnings Per Share for LABORATORIO REIG JOFRE S A is roughly  159.86 

LABORATORIO REIG Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Your Equity Center. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page